Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan

Director William Hoffman of Inari Medical, Inc. sold shares of common stock on September 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• William Hoffman, a director at Inari Medical, Inc., sold shares of the company's common stock on September 16, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
• Two transactions occurred: the first involved the sale of 32,614 shares at a weighted average price of $45.73, and the second involved the sale of 7,386 shares at a weighted average price of $46.27.
• Following these transactions, Hoffman directly owns 643,296 shares of Inari Medical, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock sales by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a routine disclosure of insider trading activity. It is common for corporate insiders to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates